Remove Licensing Remove Pharma Companies Remove Regulations
article thumbnail

Q&A: The IND Journey Phase I – Navigating Success

Advarra

The standard for the audit used depends on the type of vendor and would include the applicable regulations and ICH guidelines. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval. The term drug substance and drug product are found in the NDA regulations 21 CFR 314.3,

article thumbnail

Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150 million

The Pharma Data

The demand for an effective drug for nail fungus is high and MOB-015 can achieve a unique market position through its high antifungal effect,” says Anna Ljung, CEO of Moberg Pharma. The information was submitted for publication, through the agency of the contact persons set out above, at 8.00 CET on November 6, 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Scaling Phage Therapy

Codon

Phage-based products have been licensed for use as antibacterial agents in the sanitation , food production , and animal health industries. But one can only train a phage so much before it has changed, genetically, to the point where it is now considered a different phage to the one the regulator initially approved.

Therapies 135
article thumbnail

Article FDA Thank You FDA gives companies leeway to go after misinformation, but not free reign

Agency IQ

BY LAURA DIANGELO, MPH | JUL 10, 2024 3:47 PM CDT Regulatory background: The FDA is responsible for overseeing information about regulated products. The FDA is responsible for ensuring that medical products are adequately labeled in accordance with federal regulations, including the product’s “intended use” and relevant safety information.

FDA 40
article thumbnail

Navigating the AI revolution: a roadmap for pharma’s future

Drug Target Review

The journey from distrust to collaboration among industry, academia and regulators will expedite integration, minimise clinical failures and enhance economic sustainability. Techbio companies have initiated this approach. FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine.

article thumbnail

10 Biopharma Stories to Look Forward to in 2021

The Pharma Data

The reason for this is still not understood and many regulators may want it to be explained before authorizing it for broader use. In short, the advisory committee did not vote to recommend the drug to the agency, which has a PDUFA date of March 7, 2021 to decide whether to approve the aducanumab Biologics License Application (BLA).

Vaccine 52
article thumbnail

AstraZeneca Closes in on Potential UK Vaccine Authorization and Other COVID-19 News

The Pharma Data

Recombinant monoclonal antibodies are designed to enhance the immune system’s ability to regulate cell functions. More Vaccine Development : In France, specialty vaccine company Valneva SE announced it was launching a Phase I/II study for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. government in September.

Vaccine 52